3.20.1 html 147 269 1 true 48 0 false 5 false false R1.htm 0001000 - Document - Cover Page Sheet http://www.acceleronpharma.com/role/CoverPage Cover Page Cover 1 false false R2.htm 1001000 - Statement - Condensed Consolidated Balance Sheets Sheet http://www.acceleronpharma.com/role/CondensedConsolidatedBalanceSheets Condensed Consolidated Balance Sheets Statements 2 false false R3.htm 1001501 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) Sheet http://www.acceleronpharma.com/role/CondensedConsolidatedBalanceSheetsParenthetical Condensed Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 1002000 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Loss Sheet http://www.acceleronpharma.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss Condensed Consolidated Statements of Operations and Comprehensive Loss Statements 4 false false R5.htm 1003000 - Statement - Condensed Consolidated Statements of Stockholders' Equity Sheet http://www.acceleronpharma.com/role/CondensedConsolidatedStatementsOfStockholdersEquity Condensed Consolidated Statements of Stockholders' Equity Statements 5 false false R6.htm 1003501 - Statement - Consolidated Statements of Stockholders' Equity (Parenthetical) Sheet http://www.acceleronpharma.com/role/ConsolidatedStatementsOfStockholdersEquityParenthetical Consolidated Statements of Stockholders' Equity (Parenthetical) Statements 6 false false R7.htm 1004000 - Statement - Condensed Consolidated Statements of Cash Flows Sheet http://www.acceleronpharma.com/role/CondensedConsolidatedStatementsOfCashFlows Condensed Consolidated Statements of Cash Flows Statements 7 false false R8.htm 2101100 - Disclosure - Nature of Business Sheet http://www.acceleronpharma.com/role/NatureOfBusiness Nature of Business Notes 8 false false R9.htm 2102100 - Disclosure - Basis of Presentation Sheet http://www.acceleronpharma.com/role/BasisOfPresentation Basis of Presentation Notes 9 false false R10.htm 2103100 - Disclosure - Use of Estimates Sheet http://www.acceleronpharma.com/role/UseOfEstimates Use of Estimates Notes 10 false false R11.htm 2104100 - Disclosure - Segment Information Sheet http://www.acceleronpharma.com/role/SegmentInformation Segment Information Notes 11 false false R12.htm 2105100 - Disclosure - Cash Equivalents and Short-term and Long-term Investments Sheet http://www.acceleronpharma.com/role/CashEquivalentsAndShortTermAndLongTermInvestments Cash Equivalents and Short-term and Long-term Investments Notes 12 false false R13.htm 2106100 - Disclosure - Restricted Cash Sheet http://www.acceleronpharma.com/role/RestrictedCash Restricted Cash Notes 13 false false R14.htm 2107100 - Disclosure - Concentrations of Credit Risk and Off-Balance Sheet Risk Sheet http://www.acceleronpharma.com/role/ConcentrationsOfCreditRiskAndOffBalanceSheetRisk Concentrations of Credit Risk and Off-Balance Sheet Risk Notes 14 false false R15.htm 2108100 - Disclosure - Fair Value Measurements Sheet http://www.acceleronpharma.com/role/FairValueMeasurements Fair Value Measurements Notes 15 false false R16.htm 2109100 - Disclosure - Net Loss Per Share Sheet http://www.acceleronpharma.com/role/NetLossPerShare Net Loss Per Share Notes 16 false false R17.htm 2110100 - Disclosure - Comprehensive Loss Sheet http://www.acceleronpharma.com/role/ComprehensiveLoss Comprehensive Loss Notes 17 false false R18.htm 2112100 - Disclosure - Recent Accounting Pronouncements Sheet http://www.acceleronpharma.com/role/RecentAccountingPronouncements Recent Accounting Pronouncements Notes 18 false false R19.htm 2113100 - Disclosure - Warrants Sheet http://www.acceleronpharma.com/role/Warrants Warrants Notes 19 false false R20.htm 2114100 - Disclosure - Commitments and Contingencies Sheet http://www.acceleronpharma.com/role/CommitmentsAndContingencies Commitments and Contingencies Notes 20 false false R21.htm 2115100 - Disclosure - Significant Agreements Sheet http://www.acceleronpharma.com/role/SignificantAgreements Significant Agreements Notes 21 false false R22.htm 2116100 - Disclosure - Stock-Based Compensation Sheet http://www.acceleronpharma.com/role/StockBasedCompensation Stock-Based Compensation Notes 22 false false R23.htm 2117100 - Disclosure - Income Taxes Sheet http://www.acceleronpharma.com/role/IncomeTaxes Income Taxes Notes 23 false false R24.htm 2118100 - Disclosure - Related Party Transactions Sheet http://www.acceleronpharma.com/role/RelatedPartyTransactions Related Party Transactions Notes 24 false false R25.htm 2202201 - Disclosure - Basis of Presentation (Policies) Sheet http://www.acceleronpharma.com/role/BasisOfPresentationPolicies Basis of Presentation (Policies) Policies http://www.acceleronpharma.com/role/RecentAccountingPronouncements 25 false false R26.htm 2305301 - Disclosure - Cash Equivalents and Short-term and Long-term Investments (Tables) Sheet http://www.acceleronpharma.com/role/CashEquivalentsAndShortTermAndLongTermInvestmentsTables Cash Equivalents and Short-term and Long-term Investments (Tables) Tables http://www.acceleronpharma.com/role/CashEquivalentsAndShortTermAndLongTermInvestments 26 false false R27.htm 2306301 - Disclosure - Restricted Cash (Tables) Sheet http://www.acceleronpharma.com/role/RestrictedCashTables Restricted Cash (Tables) Tables http://www.acceleronpharma.com/role/RestrictedCash 27 false false R28.htm 2308301 - Disclosure - Fair Value Measurements (Tables) Sheet http://www.acceleronpharma.com/role/FairValueMeasurementsTables Fair Value Measurements (Tables) Tables http://www.acceleronpharma.com/role/FairValueMeasurements 28 false false R29.htm 2309301 - Disclosure - Net Loss Per Share (Tables) Sheet http://www.acceleronpharma.com/role/NetLossPerShareTables Net Loss Per Share (Tables) Tables http://www.acceleronpharma.com/role/NetLossPerShare 29 false false R30.htm 2313301 - Disclosure - Warrants (Tables) Sheet http://www.acceleronpharma.com/role/WarrantsTables Warrants (Tables) Tables http://www.acceleronpharma.com/role/Warrants 30 false false R31.htm 2316301 - Disclosure - Stock-Based Compensation (Tables) Sheet http://www.acceleronpharma.com/role/StockBasedCompensationTables Stock-Based Compensation (Tables) Tables http://www.acceleronpharma.com/role/StockBasedCompensation 31 false false R32.htm 2404401 - Disclosure - Segment Information (Details) Sheet http://www.acceleronpharma.com/role/SegmentInformationDetails Segment Information (Details) Details http://www.acceleronpharma.com/role/SegmentInformation 32 false false R33.htm 2405402 - Disclosure - Cash Equivalents and Short-term and Long-term Investments Summary of Available-for-sale Securities With Unrealized Losses (Details) Sheet http://www.acceleronpharma.com/role/CashEquivalentsAndShortTermAndLongTermInvestmentsSummaryOfAvailableForSaleSecuritiesWithUnrealizedLossesDetails Cash Equivalents and Short-term and Long-term Investments Summary of Available-for-sale Securities With Unrealized Losses (Details) Details 33 false false R34.htm 2405403 - Disclosure - Cash Equivalents and Short-term and Long-term Investments - Narrative (Details) Sheet http://www.acceleronpharma.com/role/CashEquivalentsAndShortTermAndLongTermInvestmentsNarrativeDetails Cash Equivalents and Short-term and Long-term Investments - Narrative (Details) Details http://www.acceleronpharma.com/role/CashEquivalentsAndShortTermAndLongTermInvestmentsTables 34 false false R35.htm 2405404 - Disclosure - Cash Equivalents and Short-term and Long-term Investments - Summary of Cash, Cash Equivalents and Available-for-sale Securities (Details) Sheet http://www.acceleronpharma.com/role/CashEquivalentsAndShortTermAndLongTermInvestmentsSummaryOfCashCashEquivalentsAndAvailableForSaleSecuritiesDetails Cash Equivalents and Short-term and Long-term Investments - Summary of Cash, Cash Equivalents and Available-for-sale Securities (Details) Details 35 false false R36.htm 2406402 - Disclosure - Restricted Cash (Details) Sheet http://www.acceleronpharma.com/role/RestrictedCashDetails Restricted Cash (Details) Details http://www.acceleronpharma.com/role/RestrictedCashTables 36 false false R37.htm 2407401 - Disclosure - Concentrations of Credit Risk and Off-Balance Sheet Risk (Details) Sheet http://www.acceleronpharma.com/role/ConcentrationsOfCreditRiskAndOffBalanceSheetRiskDetails Concentrations of Credit Risk and Off-Balance Sheet Risk (Details) Details http://www.acceleronpharma.com/role/ConcentrationsOfCreditRiskAndOffBalanceSheetRisk 37 false false R38.htm 2408402 - Disclosure - Fair Value Measurements - Financial Instrument at Fair Value Schedule (Details) Sheet http://www.acceleronpharma.com/role/FairValueMeasurementsFinancialInstrumentAtFairValueScheduleDetails Fair Value Measurements - Financial Instrument at Fair Value Schedule (Details) Details 38 false false R39.htm 2408403 - Disclosure - Fair Value Measurements - Preferred and Common Stock Warrant Liability Rollforward (Details) Sheet http://www.acceleronpharma.com/role/FairValueMeasurementsPreferredAndCommonStockWarrantLiabilityRollforwardDetails Fair Value Measurements - Preferred and Common Stock Warrant Liability Rollforward (Details) Details 39 false false R40.htm 2409402 - Disclosure - Net Loss Per Share (Details) Sheet http://www.acceleronpharma.com/role/NetLossPerShareDetails Net Loss Per Share (Details) Details http://www.acceleronpharma.com/role/NetLossPerShareTables 40 false false R41.htm 2413402 - Disclosure - Warrants (Details) Sheet http://www.acceleronpharma.com/role/WarrantsDetails Warrants (Details) Details http://www.acceleronpharma.com/role/WarrantsTables 41 false false R42.htm 2415401 - Disclosure - Significant Agreements - Celgene, Accounting Analysis (Details) Sheet http://www.acceleronpharma.com/role/SignificantAgreementsCelgeneAccountingAnalysisDetails Significant Agreements - Celgene, Accounting Analysis (Details) Details 42 false false R43.htm 2415402 - Disclosure - Significant Agreements - Other Agreements (Details) Sheet http://www.acceleronpharma.com/role/SignificantAgreementsOtherAgreementsDetails Significant Agreements - Other Agreements (Details) Details 43 false false R44.htm 2416402 - Disclosure - Stock-Based Compensation - Schedule of Stock-Based Compensation Costs Recognized (Details) Sheet http://www.acceleronpharma.com/role/StockBasedCompensationScheduleOfStockBasedCompensationCostsRecognizedDetails Stock-Based Compensation - Schedule of Stock-Based Compensation Costs Recognized (Details) Details 44 false false R45.htm 2416403 - Disclosure - Stock-Based Compensation - Schedule of Weighted-Average Assumptions Used for Estimating Fair Value (Details) Sheet http://www.acceleronpharma.com/role/StockBasedCompensationScheduleOfWeightedAverageAssumptionsUsedForEstimatingFairValueDetails Stock-Based Compensation - Schedule of Weighted-Average Assumptions Used for Estimating Fair Value (Details) Details 45 false false R46.htm 2416404 - Disclosure - Stock-Based Compensation - Summary of Stock Option Activity (Details) Sheet http://www.acceleronpharma.com/role/StockBasedCompensationSummaryOfStockOptionActivityDetails Stock-Based Compensation - Summary of Stock Option Activity (Details) Details 46 false false R47.htm 2416405 - Disclosure - Stock-Based Compensation - Schedule of Nonvested Restricted Stock Activity (Details) Sheet http://www.acceleronpharma.com/role/StockBasedCompensationScheduleOfNonvestedRestrictedStockActivityDetails Stock-Based Compensation - Schedule of Nonvested Restricted Stock Activity (Details) Details 47 false false R48.htm 2418401 - Disclosure - Related Party Transactions (Details) Sheet http://www.acceleronpharma.com/role/RelatedPartyTransactionsDetails Related Party Transactions (Details) Details http://www.acceleronpharma.com/role/RelatedPartyTransactions 48 false false All Reports Book All Reports xlrn-20200331.htm xlrn-20200331.xsd xlrn-20200331_cal.xml xlrn-20200331_def.xml xlrn-20200331_lab.xml xlrn-20200331_pre.xml xlrn-20200331xexhibit1.htm xlrn-20200331xexhibit311.htm xlrn-20200331xexhibit312.htm xlrn-20200331xexhibit32.htm http://fasb.org/us-gaap/2019-01-31 http://xbrl.sec.gov/dei/2019-01-31 http://fasb.org/srt/2019-01-31 true true